Ultra-processed foods and rheumatic disease study
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study explores how eating ultra-processed foods affects people with chronic rheumatic diseases like rheumatoid arthritis, spondyloarthritis, or osteoarthritis. It aims to understand if diet plays a role in symptom management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have a chronic rheumatic disease (rheumatoid arthritis, spondyloarthritis, or osteoarthritis)
- You can fill out questionnaires about your health and diet
- You are not under a legal guardianship or court protection
- You are willing to participate
- You do not have two rheumatic diseases at the same time
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how diet affects people with different types of arthritis and related autoimmune conditions. If you are a UCF Health patient between 18 and 65, you may be able to help researchers learn more about which foods help or worsen symptoms.
This study tests whether an anti-inflammatory diet can help people with rheumatoid arthritis by lowering inflammation and disease activity. You may join if your symptoms are currently mild to moderate and you haven’t recently changed medications or your treatment plan.
This study looks at people with early arthritis related to rheumatoid arthritis, psoriatic arthritis, or psoriasis. Researchers want to understand how these early conditions behave and may help guide better treatment decisions.
This study tests whether combining resistance exercise (like strength training) with an anti-inflammatory diet can help reduce pain, improve daily function, and boost quality of life for people with rheumatoid arthritis.
This trial measures levels of a protein called CCL-21 in the blood of people with rheumatoid arthritis, osteoarthritis, and healthy volunteers. The goal is to see if CCL-21 levels relate to disease activity and could help track inflammation.
This study examines joint tissue from people with different types of arthritis to understand the disease better. It may help researchers develop better treatments in the future.
Hear when a new Rheumatoid arthritis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.